세균성 질환 진단 시장(2026-2030년)

The global bacterial disease diagnostics market is forecasted to grow by USD 4996 mn during 2025-2030, accelerating at a CAGR of 6.9% during the forecast period. The report on the global bacterial disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of target infectious diseases and global pathogen outbreaks, accelerated proliferation of antimicrobial resistance and public health mandates, technological integration of molecular assays and point of care testing innovation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global bacterial disease diagnostics market is segmented as below:

By Product

• Consumables
• Instruments

By End-User

• Hospitals
• Labs

By Method

• Culture and isolation
• Microscopy
• Molecular diagnostics
• Serological testing
• Others

By Disease Type

• Respiratory infections
• Gastrointestinal infections
• Genitourinary infections
• Skin and soft tissue infections
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the shift towards high-throughput syndromic multiplex testing panels as one of the prime reasons driving the global bacterial disease diagnostics market growth during the next few years. Also, expansion of ai and ml in decentralized phenotypic profiling and accelerated proliferation of microfluidic poc assays and regulatory harmonization will lead to sizable demand in the market.

The report on the global bacterial disease diagnostics market covers the following areas:

• Global bacterial disease diagnostics market sizing
• Global bacterial disease diagnostics market forecast
• Global bacterial disease diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global bacterial disease diagnostics market vendors that include Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Bruker Corp., Cepheid Inc., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Hardy Diagnostics, Hologic Inc., Liofilchem Srl, Meridian Bioscience Inc., QIAGEN N.V., QuidelOrtho Corp., Seegene Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc.. Also, the global bacterial disease diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Method
  • Executive Summary - Chart on Market Segmentation by Disease Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Bacterial Disease Diagnostics Market 2020 - 2024
  • Historic Market Size - Data Table on Global Bacterial Disease Diagnostics Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Method segment analysis 2020 - 2024
  • Historic Market Size - Method Segment 2020 - 2024 ($ million)
• 5.5 Disease Type segment analysis 2020 - 2024
  • Historic Market Size - Disease Type Segment 2020 - 2024 ($ million)
• 5.6 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.7 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global bacterial disease diagnostics market
• 6.2 Impact of geopolitical conflicts on global bacterial disease diagnostics market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Consumables - Market size and forecast 2025-2030
• 8.4 Instruments - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2025-2030
• 9.4 Labs - Market size and forecast 2025-2030
• 9.5 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Method

• 10.1 Market segments
• 10.2 Comparison by Method
• 10.3 Culture and isolation - Market size and forecast 2025-2030
• 10.4 Microscopy - Market size and forecast 2025-2030
• 10.5 Molecular diagnostics - Market size and forecast 2025-2030
• 10.6 Serological testing - Market size and forecast 2025-2030
• 10.7 Others - Market size and forecast 2025-2030
• 10.8 Market opportunity by Method
  • Market opportunity by Method ($ million)

11 Market Segmentation by Disease Type

• 11.1 Market segments
• 11.2 Comparison by Disease Type
• 11.3 Respiratory infections - Market size and forecast 2025-2030
• 11.4 Gastrointestinal infections - Market size and forecast 2025-2030
• 11.5 Genitourinary infections - Market size and forecast 2025-2030
• 11.6 Skin and soft tissue infections - Market size and forecast 2025-2030
• 11.7 Others - Market size and forecast 2025-2030
• 11.8 Market opportunity by Disease Type
  • Market opportunity by Disease Type ($ million)

12 Customer Landscape

• 12.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

• 13.1 Geographic segmentation
• 13.2 Geographic comparison
• 13.3 North America - Market size and forecast 2025-2030
  • 13.3.1 US - Market size and forecast 2025-2030
  • 13.3.2 Canada - Market size and forecast 2025-2030
  • 13.3.3 Mexico - Market size and forecast 2025-2030
• 13.4 Europe - Market size and forecast 2025-2030
  • 13.4.1 Germany - Market size and forecast 2025-2030
  • 13.4.2 UK - Market size and forecast 2025-2030
  • 13.4.3 France - Market size and forecast 2025-2030
  • 13.4.4 Italy - Market size and forecast 2025-2030
  • 13.4.5 Spain - Market size and forecast 2025-2030
  • 13.4.6 The Netherlands - Market size and forecast 2025-2030
• 13.5 Asia - Market size and forecast 2025-2030
  • 13.5.1 China - Market size and forecast 2025-2030
  • 13.5.2 India - Market size and forecast 2025-2030
  • 13.5.3 Japan - Market size and forecast 2025-2030
  • 13.5.4 South Korea - Market size and forecast 2025-2030
  • 13.5.5 Indonesia - Market size and forecast 2025-2030
  • 13.5.6 Thailand - Market size and forecast 2025-2030
• 13.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 13.6.1 Brazil - Market size and forecast 2025-2030
  • 13.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 13.6.3 UAE - Market size and forecast 2025-2030
  • 13.6.4 Turkey - Market size and forecast 2025-2030
  • 13.6.5 Argentina - Market size and forecast 2025-2030
  • 13.6.6 Colombia - Market size and forecast 2025-2030
  • 13.6.7 South Africa - Market size and forecast 2025-2030
  • 13.6.8 Israel - Market size and forecast 2025-2030
• 13.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

14 Drivers, Challenges, and Opportunity

• 14.1 Market drivers
  • Rising incidence of target infectious diseases and global pathogen outbreaks
  • Accelerated proliferation of antimicrobial resistance and public health mandates
  • Technological integration of molecular assays and point of care testing innovation
• 14.2 Market challenges
  • Substantial capital demands and prohibitive manufacturing costs of advanced diagnostic instrumentation
  • Critical shortage of skilled laboratory personnel and infrastructure deficiencies
  • Stringent and protracted regulatory approval pathways across international jurisdictions
• 14.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 14.4 Market opportunities
  • Shift towards high-throughput syndromic multiplex testing panels
  • Expansion of AI and ML in decentralized phenotypic profiling
  • Accelerated proliferation of microfluidic POC assays and regulatory harmonization

15 Competitive Landscape

• 15.1 Overview
• 15.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 15.3 Landscape disruption
  • Overview on factors of disruption
• 15.4 Industry risks
  • Impact of key risks on business

16 Competitive Analysis

• 16.1 Companies profiled
  • Companies covered
• 16.2 Company ranking index
  • Company ranking index
• 16.3 Market positioning of companies
  • Matrix on companies position and classification
• 16.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 16.5 Beckman Coulter Inc.
  • Beckman Coulter Inc. - Overview
  • Beckman Coulter Inc. - Product / Service
  • Beckman Coulter Inc. - Key offerings
  • SWOT
• 16.6 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 16.7 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 16.8 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 16.9 Bruker Corp.
  • Bruker Corp. - Overview
  • Bruker Corp. - Business segments
  • Bruker Corp. - Key offerings
  • Bruker Corp. - Segment focus
  • SWOT
• 16.10 Cepheid Inc.
  • Cepheid Inc. - Overview
  • Cepheid Inc. - Product / Service
  • Cepheid Inc. - Key offerings
  • SWOT
• 16.11 DiaSorin SpA
  • DiaSorin SpA - Overview
  • DiaSorin SpA - Business segments
  • DiaSorin SpA - Key offerings
  • DiaSorin SpA - Segment focus
  • SWOT
• 16.12 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 16.13 Hologic Inc.
  • Hologic Inc. - Overview
  • Hologic Inc. - Product / Service
  • Hologic Inc. - Key offerings
  • SWOT
• 16.14 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key offerings
  • SWOT
• 16.15 QuidelOrtho Corp.
  • QuidelOrtho Corp. - Overview
  • QuidelOrtho Corp. - Business segments
  • QuidelOrtho Corp. - Key offerings
  • QuidelOrtho Corp. - Segment focus
  • SWOT
• 16.16 Seegene Inc.
  • Seegene Inc. - Overview
  • Seegene Inc. - Product / Service
  • Seegene Inc. - Key offerings
  • SWOT
• 16.17 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 16.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

17 Appendix

• 17.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 17.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 17.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 17.4 Research methodology
  • Research methodology
• 17.5 Data procurement
  • Information sources
• 17.6 Data validation
  • Data validation
• 17.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 17.8 Data synthesis
  • Data synthesis
• 17.9 360 degree market analysis
  • 360 degree market analysis
• 17.10 List of abbreviations
  • List of abbreviations